Stock LYKALABS LYKA LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Lyka Labs Limited Bombay S.E.

Equities

LYKALABS

INE933A01014

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-06-14 EDT 		5-day change 1st Jan Change
108.8 INR +0.65% Intraday chart for Lyka Labs Limited +2.45% -12.61%
02-08 Lyka Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Lyka Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Business Summary

Lyka Labs Limited is an India-based company that is engaged in the business of pharmaceutical and related activities, including research. The Company is focused on lyophilization - formulations/bulk sterile active pharmaceutical ingredients (APIs), and new product development including novel drug delivery systems in both topical preparation and lyophilized products. The Company manufactures pharmaceutical products, such as dry powder, liquid injections, lyophilized injections, ointment/creams and lotions, and external preparations for several international markets and the domestic market. It offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, anti-fungal, anti-malarial, anti-bacterial, corticosteroid hormones and cephalosporins. The Company's subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.

Number of employees: 296

Sales per Business

INR in Million2022Weight2023Weight Delta
Formulations
91.9 %
1,754 90.4 % 855 91.9 % -51.25%
Bulk Drugs
3.0 %
82 4.2 % 28 3.0 % -65.50%
Processing Charges
2.4 %
79 4.1 % 23 2.4 % -71.36%
Commission
1.1 %
17 0.9 % 10 1.1 % -40.22%
Royalty
0.7 %
4 0.2 % 6 0.7 % +70.39%
Export Incentives
0.5 %
5 0.3 % 4 0.5 % -13.61%
Other Operating Income
0.4 %
0 0.0 % 4 0.4 % +4,940.00%

Sales per region

INR in Million2022Weight2023Weight Delta
Rest of World
52.8 %
535 29.2 % 466 52.8 % -12.95%
India
47.2 %
1,300 70.8 % 417 47.2 % -67.91%

Managers

Managers TitleAgeSince
Kunal Narendra Gandhi CEO
 Chief Executive Officer 37 10-03-31
Yogesh Babulal Shah DFI
 Director of Finance/CFO 63 14-06-30
Kishore P. Shah CMP
 Compliance Officer - 22-11-08

Members of the board

Members of the board TitleAgeSince
Prashant Premchand Godha BRD
 Director/Board Member 76 22-08-07
Babulal Harakchand Jain CHM
 Chairman 73 23-08-07
Yogesh Babulal Shah DFI
 Director of Finance/CFO 63 14-06-30
Kunal Narendra Gandhi CEO
 Chief Executive Officer 37 10-03-31
Dhara P. Shah BRD
 Director/Board Member 36 21-08-03
Shashil Mendonsa BRD
 Director/Board Member - 22-08-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 35,690,000 14,386,677 ( 40.31 %) 0 40.31 %

Shareholders

NameEquities%Valuation
IPCA LABORATORIES LIMITED
36.34 %
12,024,923 36.34 % 16 M ₹
Kunal Narendra Gandhi
7.311 %
2,419,152 7.311 % 3 M ₹
Nehal Narendra Gandhi
6.866 %
2,272,082 6.866 % 3 M ₹
Enai Trading & Investment Pvt Ltd.
3.003 %
993,827 3.003 % 1 M ₹
Pranay Godha
0.9066 %
300,000 0.9066 % 387 798 ₹
Premchand Gigalal Godha
0.0329 %
10,900 0.0329 % 14 090 ₹
Usha P Godha
0.0323 %
10,686 0.0323 % 13 813 ₹
Neetu Godha
0.0302 %
10,000 0.0302 % 12 927 ₹
Bhawna Godha
0.0181 %
6,000 0.0181 % 7 756 ₹

Company contact information

Lyka Labs Ltd.

Ground Floor, Spencer Building 30, Forjett Street

400036, Mumbai

+91 22 6611 2200

http://www.lykalabs.com
address Lyka Labs Limited(LYKALABS)

Group companies

NameCategory and Sector
Lyka BDR International Ltd.
Logo Lyka BDR International Ltd.

Lyka BDR International Ltd.

Pharmaceuticals: MajorHealth Technology

Lyka BDR International Ltd. manufactures and markets finished pharmaceutical formulations and ready-to-fill lyophilized sterile active pharmaceutical ingredients products. It markets formulations in various dosage forms. The firm also sells human and veterinary products in Sudan. The company was founded on July 19, 1993 and is headquartered in Mumbai, India.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
PFIZER, INC. Stock Pfizer, Inc.
-4.38% 156B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LYKALABS Stock
  4. LYKALABS Stock
  5. Company Lyka Labs Limited